Nasdaq led all other U.S. exchanges in the first quarter this year when it came to bringing companies public.
The bourse racked up 74 new U.S. listings which included 45 initial public offerings.
Combined proceeds raised by Nasdaq’s first quarter IPOs totaled approximately $2.6 billion, a 20 percent increase from first quarter figures in 2013. In addition, 98 percent of NASDAQ’s IPOs filed as “emerging growth companies,” the new class of issuer created under the JOBS Act.
Among the first quarter highlights:
— NASDAQ’s first quarter IPOs have returned on average an increase of 28.2 percent from their offer price, above the market average return for all U.S. IPOs of 24.3 percent.
— 32 healthcare companies listed on NASDAQ to date in the first quarter, buoyed by a pipeline of 22 biotech listings.
— 100 percent of all biotechnology IPOs in the U.S. in 2014 have listed on NASDAQ.
— NASDAQ’s healthcare IPOs are up an average of 30 percent from their offer price.
— NASDAQ welcomed 8 financial companies and 3 technology companies to date in the first quarter.
— NASDAQ’s technology IPOs in 2014 are up an average of 53.2 percent from their offer price to date.
— 92 percent of venture capital-backed IPOs listed with NASDAQ to date in the first quarter.
— Venture capital and private equity-sponsored IPOs raised more than $1.9 billion in combined proceeds.
